Melanoma Vaccines Show Promise
While immunotherapy has transformed way melanoma is treated, about half of patients still do not respond. Researchers are pursuing multiple strategies to understand why this happens and to develop strategies to jumpstart a response. One approach showing promise in early clinical trials, comes in the form of new personalized vaccines being developed by Ugur Sahin of Johannes Gutenberg-Universität Mainz and BioNTech.
What’s Next for the Microbiome in Melanoma?
By Kristen Mueller, Ph.D., MRA Scientific Program Director | 11 April 2019 In Science, Treatment
We know that the billions of bacteria that live in our bodies can impact the way we respond to immunotherapy, but can we harness this help more patients respond these life-saving drugs?
Overcoming Targeted Therapy Resistance
Targeted therapies work well for many patients, but most will go on to develop acquired resistance. Researchers are working to address this challenge. Learn about two promising examples.
Unchartered Territory: When Should Patients Stop Immunotherapy?
For melanoma patients, deciding when to discontinue treatment is a difficult decision. should the general ‘rule of thumb’ of treating patients with advanced disease until progression still apply? In the absence of definitive data – what does indirect data tell us?
Melanoma Treatment Advances – 2018 in Review
2018 brought new and expanded drug approvals that give patients, doctors, and their families more treatment options with fewer side effects. Learn more about important melanoma treatment advances in 2018.
MRA Advisor & Grantee Dr. Allison Awarded Nobel Prize for Transforming Cancer Care
MRA Scientific Advisory Panel Member & Grantee Dr. Allison Awarded Nobel Prize for his pioneering research to harness the power of the immune system to attack cancer. His work in immunotherapy, which began in the 1990’s, was audacious at the time. It helped to mainstream an entirely new class of tools in the arsenal against cancer; joining the likes of chemotherapy, radiation, and surgery.
Connecting the Dots: MRA’s 2017-2018 Annual Report
In our 2017/18 report, we are proud to showcase many key achievements from the past year. Check out the annual report to learn more about the research we’ve funded, the partnerships we’ve forged, the progress we’ve made and the donors who help to make it all possible.
Health Literacy Month: How to Ask Your Doctor about Melanoma Clinical Trials
If you’ve ever had a hard time understanding your doctor or following directions on a medicine bottle, you’re definitely not alone. Understanding health information is a challenge for at least 90 million Americans today. In honor of Health Literacy Month, we highlighted some of the ways patients can be feel empowered to ask questions and access better care.